Prof. Hadassa Degani studied the mechanisms that supply cancerous tumors with oxygen and nutrients. Using magnetic resonance imaging, she developed a new technique, called 3TP, that produces an image of blood vessels feeding the tumor and makes it possible to distinguish between malignant and benign growths.
Application
In 2003, the non-invasive 3TP method received FDA clearance for use in the detection of breast and prostate cancer. It enables doctors to distinguish between malignant tumors and benign lumps by scanning instead of cutting.
Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the interferon-beta gene and designed several methods for producing the interferon-beta protein.
Application
Beta interferon, a drug that alleviates certain symptoms of multiple sclerosis, is produced on the basis of Revel’s research. It is manufactured by InterPharm Laboratories Ltd. in Kiryat Weizmann under the name Rebif®.
Our website uses cookies to enhance user experience by remembering your preferences and analyzing website traffic. For more information about how we use cookies please read our
3TP Method for Detection of Breast and Prostate Cancer
Application